Alkermes Current Ratio 2006-2019 | ALKS

Alkermes current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Alkermes Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.96B $0.39B 2.46
2019-09-30 $1.00B $0.37B 2.69
2019-06-30 $1.00B $0.33B 2.98
2019-03-31 $0.96B $0.33B 2.94
2018-12-31 $0.98B $0.34B 2.89
2018-09-30 $0.87B $0.31B 2.85
2018-06-30 $0.84B $0.29B 2.92
2018-03-31 $0.78B $0.28B 2.83
2017-12-31 $0.81B $0.29B 2.78
2017-09-30 $0.78B $0.26B 3.05
2017-06-30 $0.80B $0.23B 3.54
2017-03-31 $0.76B $0.21B 3.60
2016-12-31 $0.79B $0.21B 3.73
2016-09-30 $0.81B $0.19B 4.24
2016-06-30 $0.93B $0.24B 3.93
2016-03-31 $0.84B $0.22B 3.74
2015-12-31 $0.76B $0.24B 3.20
2015-09-30 $1.00B $0.20B 4.99
2015-06-30 $1.02B $0.13B 7.58
2015-03-31 $1.00B $0.11B 8.79
2014-12-31 $0.88B $0.13B 6.72
2014-09-30 $0.81B $0.11B 7.38
2014-06-30 $0.89B $0.10B 8.68
2014-03-31 $0.78B $0.09B 8.37
2013-12-31 $0.57B $0.10B 5.65
2013-09-30 $0.52B $0.07B 7.10
2013-06-30 $0.42B $0.07B 5.81
2013-03-31 $0.41B $0.09B 4.76
2012-12-31 $0.39B $0.08B 5.02
2012-09-30 $0.36B $0.07B 5.16
2012-06-30 $0.35B $0.07B 4.95
2012-03-31 $0.40B $0.09B 4.43
2011-12-31 $0.38B $0.10B 3.86
2011-09-30 $0.36B $0.09B 3.94
2011-06-30 $0.31B $0.05B 6.77
2011-03-31 $0.25B $0.05B 5.26
2010-12-31 $0.23B $0.04B 6.05
2010-09-30 $0.30B $0.04B 8.54
2010-06-30 $0.35B $0.08B 4.58
2010-03-31 $0.34B $0.09B 3.71
2009-12-31 $0.29B $0.06B 5.10
2009-09-30 $0.36B $0.06B 6.36
2009-06-30 $0.37B $0.05B 7.10
2009-03-31 $0.38B $0.07B 5.45
2008-12-31 $0.41B $0.07B 6.20
2008-09-30 $0.40B $0.05B 8.79
2008-06-30 $0.43B $0.04B 10.80
2008-03-31 $0.41B $0.04B 9.83
2007-12-31 $0.58B $0.04B 14.77
2007-09-30 $0.43B $0.03B 13.44
2007-06-30 $0.42B $0.04B 11.10
2007-03-31 $0.43B $0.06B 6.98
2006-12-31 $0.43B $0.07B 6.24
2006-09-30 $0.41B $0.10B 4.23
2006-06-30 $0.43B $0.09B 4.67
2006-03-31 $0.35B $0.13B 2.77
2005-12-31 $0.36B $0.14B 2.60
2005-09-30 $0.37B $0.13B 2.95
2005-06-30 $0.37B $0.10B 3.78
2005-03-31 $0.23B $0.02B 9.62
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.346B $1.171B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $123.140B 14.08
Gilead Sciences (GILD) United States $94.011B 12.16
CSL (CSLLY) Australia $87.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $64.213B 58.28
Regeneron Pharmaceuticals (REGN) United States $55.175B 23.37
Biogen (BIIB) United States $52.430B 8.95
Illumina (ILMN) United States $41.254B 42.65
Alexion Pharmaceuticals (ALXN) United States $21.037B 9.75
Seattle Genetics (SGEN) United States $21.018B 0.00
Incyte (INCY) United States $18.786B 40.31
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.363B 614.08
Genmab (GMAB) Denmark $13.679B 10.62
Genmab (GNMSF) Denmark $13.202B 42.46
Galapagos (GLPG) Belgium $12.563B 38.39
Alnylam Pharmaceuticals (ALNY) United States $12.384B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.934B 51.10
Moderna (MRNA) United States $10.535B 0.00
BioNTech SE (BNTX) Germany $10.318B 0.00
Exact Sciences (EXAS) United States $9.263B 0.00
QIAGEN (QGEN) Netherlands $9.158B 27.92
BeiGene (BGNE) Cayman Islands $8.861B 0.00
Sarepta Therapeutics (SRPT) United States $7.776B 0.00
Bio-Techne Corp (TECH) United States $7.425B 50.82
ACADIA Pharmaceuticals (ACAD) United States $6.479B 0.00
Guardant Health (GH) United States $6.039B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.902B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.849B 15.46
Ascendis Pharma (ASND) Denmark $5.815B 0.00
Exelixis (EXEL) United States $5.378B 17.26
Repligen (RGEN) United States $5.034B 92.05
Acceleron Pharma (XLRN) United States $4.560B 0.00
Reata Pharmaceuticals (RETA) United States $4.474B 0.00
Immunomedics (IMMU) United States $4.045B 0.00
China Biologic Products (CBPO) China $3.936B 23.36
Global Blood Therapeutics (GBT) United States $3.573B 0.00
Blueprint Medicines (BPMC) United States $3.526B 0.00
Vir Biotechnology (VIR) United States $3.523B 0.00
Mirati Therapeutics (MRTX) United States $3.341B 0.00
MorphoSys AG (MOR) Germany $3.232B 0.00
Adaptive Biotechnologies (ADPT) United States $3.152B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.107B 0.00
Emergent Biosolutions (EBS) United States $3.077B 21.36
Zai Lab (ZLAB) China $2.984B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.936B 0.00
NeoGenomics (NEO) United States $2.616B 113.41
Amicus Therapeutics (FOLD) United States $2.598B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.514B 42.57
Deciphera Pharmaceuticals (DCPH) United States $2.422B 0.00
Arena Pharmaceuticals (ARNA) United States $2.352B 6.13
Bluebird Bio (BLUE) United States $2.343B 0.00
Halozyme Therapeutics (HALO) United States $2.302B 0.00
UniQure (QURE) Netherlands $2.234B 0.00
MyoKardia (MYOK) United States $2.198B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.067B 0.00
Principia Biopharma (PRNB) United States $1.909B 0.00
Denali Therapeutics (DNLI) United States $1.863B 0.00
Fate Therapeutics (FATE) United States $1.836B 0.00
Amarin (AMRN) Ireland $1.800B 0.00
Alector (ALEC) United States $1.798B 0.00
Zymeworks (ZYME) Canada $1.626B 0.00
Eidos Therapeutics (EIDX) United States $1.616B 0.00
Arvinas (ARVN) United States $1.608B 0.00
Insmed (INSM) United States $1.591B 0.00
Viela Bio (VIE) United States $1.525B 0.00
Epizyme (EPZM) United States $1.517B 0.00
Akcea Therapeutics (AKCA) United States $1.503B 32.33
Dicerna Pharmaceuticals (DRNA) United States $1.335B 0.00
Ligand Pharmaceuticals (LGND) United States $1.291B 40.12
Inovio Pharmaceuticals (INO) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.159B 0.00
Coherus BioSciences (CHRS) United States $1.138B 13.55
Zealand Pharma (ZEAL) Denmark $1.130B 0.00
REGENXBIO (RGNX) United States $1.109B 0.00
Myriad Genetics (MYGN) United States $1.103B 19.46
PHARMA MAR SA (PHMMF) Spain $1.062B 0.00
NGM Biopharmaceuticals (NGM) United States $0.961B 0.00
Twist Bioscience (TWST) United States $0.936B 0.00
NextCure (NXTC) United States $0.928B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.855B 0.00
Intra-Cellular Therapies (ITCI) United States $0.847B 0.00
Beam Therapeutics (BEAM) United States $0.812B 0.00
Sangamo Therapeutics (SGMO) United States $0.789B 0.00
Adverum Biotechnologies (ADVM) United States $0.786B 0.00
Novavax (NVAX) United States $0.768B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.761B 0.00
I-Mab (IMAB) China $0.742B 0.00
Cytokineticsorporated (CYTK) United States $0.722B 0.00
Athenex (ATNX) United States $0.665B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Arcus Biosciences (RCUS) United States $0.663B 0.00
Retrophin (RTRX) United States $0.652B 0.00
GENFIT S.A (GNFT) France $0.627B 0.00
Cara Therapeutics (CARA) United States $0.624B 0.00
Bellus Health (BLU) Canada $0.615B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Kadmon Holdings (KDMN) United States $0.596B 0.00
Codexis (CDXS) United States $0.596B 0.00
Intellia Therapeutics (NTLA) United States $0.582B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.569B 5.00
Compugen (CGEN) Israel $0.566B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.547B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.537B 0.00
ANI Pharmaceuticals (ANIP) United States $0.532B 9.59
Nabriva Therapeutics AG (NBRV) Ireland $0.530B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.529B 0.00
Castle Biosciences (CSTL) United States $0.526B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.513B 0.00
Clovis Oncology (CLVS) United States $0.499B 0.00
Frequency Therapeutics (FREQ) United States $0.473B 0.00
Athersys (ATHX) United States $0.473B 0.00
Verastem (VSTM) United States $0.463B 0.00
Intrexon (PGEN) United States $0.462B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AC Immune SA (ACIU) Switzerland $0.460B 11.74
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Sorrento Therapeutics (SRNE) United States $0.457B 0.00
Scholar Rock Holding (SRRK) United States $0.445B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Heska (HSKA) United States $0.439B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.433B 0.00
DBV Technologies S.A (DBVT) France $0.422B 0.00
Cel-Sci (CVM) United States $0.421B 0.00
Vericel (VCEL) United States $0.420B 62.33
UROGEN PHARMA (URGN) United States $0.415B 0.00
Cue Biopharma (CUE) United States $0.401B 0.00
Morphic Holding (MORF) United States $0.400B 0.00
Anika Therapeutics (ANIK) United States $0.398B 13.71
Cellectis S.A (CLLS) France $0.386B 0.00
MiMedx (MDXG) United States $0.386B 0.00
Agenus (AGEN) United States $0.385B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.382B 0.00
BioDelivery Sciences (BDSI) United States $0.380B 43.78
Adaptimmune Therapeutics (ADAP) United Kingdom $0.368B 0.00
CytomX Therapeutics (CTMX) United States $0.354B 0.00
Mersana Therapeutics (MRSN) United States $0.352B 0.00
PDL BioPharma (PDLI) United States $0.345B 10.33
Kala Pharmaceuticals (KALA) United States $0.328B 0.00
Merus (MRUS) Netherlands $0.319B 0.00
Pfenex (PFNX) United States $0.303B 442.00
Syros Pharmaceuticals (SYRS) United States $0.302B 0.00
Cellular Biomedicine (CBMG) United States $0.293B 0.00
Precision BioSciences (DTIL) United States $0.287B 0.00
NantKwest (NK) United States $0.281B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.277B 0.00
Kamada (KMDA) Israel $0.272B 11.30
WAVE Life Sciences (WVE) Singapore $0.267B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.263B 0.00
Dynavax Technologies (DVAX) United States $0.259B 0.00
Avid Bioservices (CDMO) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.254B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.249B 0.00
Stemline Therapeutics (STML) United States $0.238B 0.00
Gritstone Oncology (GRTS) United States $0.229B 0.00
Seres Therapeutics (MCRB) United States $0.225B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Albireo Pharma (ALBO) United States $0.223B 0.00
Sutro Biopharma (STRO) United States $0.222B 0.00
MannKind (MNKD) United States $0.211B 0.00
Geron (GERN) United States $0.210B 0.00
Alcobra (ARCT) United States $0.207B 0.00
ChromaDex (CDXC) United States $0.201B 0.00
Starpharma Holdings (SPHRY) Australia $0.201B 0.00
Aduro Biotech (ADRO) United States $0.201B 0.00
Abeona Therapeutics (ABEO) United States $0.192B 0.00
XOMA (XOMA) United States $0.188B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.187B 1.68
Protagonist Therapeutics (PTGX) United States $0.177B 0.00
Prometic Life Sciences (LMNL) Canada $0.176B 0.00
HOOKIPA Pharma (HOOK) United States $0.174B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.169B 0.00
VBI Vaccines (VBIV) United States $0.167B 0.00
IVERIC Bio (ISEE) United States $0.162B 0.00
Selecta Biosciences (SELB) United States $0.160B 0.00
OSMOTICA PHARM (OSMT) United States $0.157B 0.00
Kindred Biosciences (KIN) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.153B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.151B 0.00
Dyadic (DYAI) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Fortress Biotech (FBIO) United States $0.144B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.141B 0.00
VolitionRX (VNRX) United States $0.141B 0.00
Exicure (XCUR) United States $0.140B 0.00
Aytu Bioscience (AYTU) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Affimed (AFMD) Germany $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Antibe Therapeutics (ATBPF) Canada $0.133B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
VTv Therapeutics (VTVT) United States $0.125B 0.00
Cerecor (CERC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.123B 0.00
Enzo Biochem (ENZ) United States $0.116B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.113B 4.45
Northwest Biotherapeutics (NWBO) United States $0.112B 0.00
Celyad SA (CYAD) Belgium $0.108B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Aptinyx (APTX) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.094B 2.57
TELA Bio (TELA) United States $0.091B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
IBio (IBIO) United States $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
Five Prime Therapeutics (FPRX) United States $0.087B 0.00
CorMedix Inc (CRMD) United States $0.084B 0.00
Happiness Biotech Group (HAPP) China $0.079B 0.00
Orgenesis (ORGS) United States $0.076B 4.47
Pluristem Therapeutics (PSTI) Israel $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Arbutus Biopharma (ABUS) Canada $0.072B 0.00
Cyclerion Therapeutics (CYCN) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Eton Pharmaceuticals (ETON) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.058B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
Synlogic (SYBX) United States $0.056B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Catalyst Biosciences (CBIO) United States $0.053B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Trevena (TRVN) United States $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 0.00
Cocrystal Pharma (COCP) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Advaxis (ADXS) United States $0.037B 0.00
Protalix BioTherapeutics (PLX) Israel $0.036B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.035B 0.00
Soligenix (SNGX) United States $0.035B 0.00
AmpliPhi Biosciences (ARMP) United States $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.035B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
Celsion (CLSN) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Pulmatrix (PULM) United States $0.027B 0.00
OvaScience (MLND) United States $0.026B 0.00
Menlo Therapeutics (MNLO) United States $0.025B 0.00
ATyr Pharma (LIFE) United States $0.025B 0.00
Curis (CRIS) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
BioCardia (BCDA) United States $0.020B 0.00
Alimera Sciences (ALIM) United States $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
VIVUS (VVUS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00